Literature DB >> 12088284

Sleeping sickness and the brain.

B Enanga1, R J S Burchmore, M L Stewart, M P Barrett.   

Abstract

Recent progress in understanding the neuropathological mechanisms of sleeping sickness reveals a complex relationship between the trypanosome parasite that causes this disease and the host nervous system. The pathology of late-stage sleeping sickness, in which the central nervous system is involved, is complicated and is associated with disturbances in the circadian rhythm of sleep. The blood-brain barrier, which separates circulating blood from the central nervous system, regulates the flow of materials to and from the brain. During the course of disease, the integrity of the blood-brain barrier is compromised. Dysfunction of the nervous system may be exacerbated by factors of trypanosomal origin or by host responses to parasites. Microscopic examination of cerebrospinal fluid remains the best way to confirm late-stage sleeping sickness, but this necessitates a risky lumbar puncture. Most drugs, including many trypanocides, do not cross the blood-brain barrier efficiently. Improved diagnostic and therapeutic approaches are thus urgently required. The latter might benefit from approaches which manipulate the blood-brain barrier to enhance permeability or to limit drug efflux. This review summarizes our current understanding of the neurological aspects of sleeping sickness, and envisages new research into blood-brain barrier models that are necessary to understand the interactions between trypanosomes and drugs active against them within the host nervous system.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12088284     DOI: 10.1007/s00018-002-8472-0

Source DB:  PubMed          Journal:  Cell Mol Life Sci        ISSN: 1420-682X            Impact factor:   9.261


  19 in total

Review 1.  Cardiac involvement with parasitic infections.

Authors:  Alicia Hidron; Nicholas Vogenthaler; José I Santos-Preciado; Alfonso J Rodriguez-Morales; Carlos Franco-Paredes; Anis Rassi
Journal:  Clin Microbiol Rev       Date:  2010-04       Impact factor: 26.132

2.  Erythrina abyssinica prevents meningoencephalitis in chronic Trypanosoma brucei brucei mouse model.

Authors:  Johnson Nasimolo; Stephen Gitahi Kiama; Peter Karuri Gathumbi; Andrew Ndegwa Makanya; John Maina Kagira
Journal:  Metab Brain Dis       Date:  2014-01-23       Impact factor: 3.584

3.  Flow loading induces oscillatory trajectories in a bloodstream parasite.

Authors:  Sravanti Uppaluri; Niko Heddergott; Eric Stellamanns; Stephan Herminghaus; Andreas Zöttl; Holger Stark; Markus Engstler; Thomas Pfohl
Journal:  Biophys J       Date:  2012-09-19       Impact factor: 4.033

Review 4.  Neuroparasitic infections: cestodes, trematodes, and protozoans.

Authors:  M D Walker; J R Zunt
Journal:  Semin Neurol       Date:  2005-09       Impact factor: 3.420

Review 5.  Importance of nonenteric protozoan infections in immunocompromised people.

Authors:  J L N Barratt; J Harkness; D Marriott; J T Ellis; D Stark
Journal:  Clin Microbiol Rev       Date:  2010-10       Impact factor: 26.132

6.  Severity of human african trypanosomiasis in East Africa is associated with geographic location, parasite genotype, and host inflammatory cytokine response profile.

Authors:  Lorna MacLean; John E Chisi; Martin Odiit; Wendy C Gibson; Vanessa Ferris; Kim Picozzi; Jeremy M Sternberg
Journal:  Infect Immun       Date:  2004-12       Impact factor: 3.441

7.  Distribution of suramin, an antitrypanosomal drug, across the blood-brain and blood-cerebrospinal fluid interfaces in wild-type and P-glycoprotein transporter-deficient mice.

Authors:  Lisa Sanderson; Adil Khan; Sarah Thomas
Journal:  Antimicrob Agents Chemother       Date:  2007-06-18       Impact factor: 5.191

Review 8.  Human African trypanosomiasis: pharmacological re-engagement with a neglected disease.

Authors:  M P Barrett; D W Boykin; R Brun; R R Tidwell
Journal:  Br J Pharmacol       Date:  2007-07-09       Impact factor: 8.739

Review 9.  Traversal of human and animal trypanosomes across the blood-brain barrier.

Authors:  Dennis J Grab; Peter G E Kennedy
Journal:  J Neurovirol       Date:  2008-11-18       Impact factor: 2.643

10.  New insights in staging and chemotherapy of African trypanosomiasis and possible contribution of medicinal plants.

Authors:  Paul F Seke Etet; M Fawzi Mahomoodally
Journal:  ScientificWorldJournal       Date:  2012-04-19
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.